Hospital Universitario Central de Asturias -ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2023

  1. Do Elderly Patients with Heart Failure and Reduced Ejection Fraction Benefit from Pharmacological Strategies for Prevention of Arrhythmic Events?

    Cardiology, Vol. 148, Núm. 3, pp. 195-206

  2. Identifying the patient with heart failure to be treated with vericiguat

    Current Medical Research and Opinion, Vol. 39, Núm. 5, pp. 661-669

  3. Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction

    Clinical Research in Cardiology

  4. Optimizing the management of patients with worsening heart failure: beyond heart failure hospitalization

    Expert Opinion on Pharmacotherapy, Vol. 24, Núm. 6, pp. 705-713

2022

  1. Impact of blood pressure on management and prognosis of patients treated with sacubitril/valsartan

    REC: CardioClinics, Vol. 57, Núm. 2, pp. 116-122

2021

  1. Initiation and titration of sacubitril/valsartan in different types of centers

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 92-97

2019

  1. Sex Influence on the Efficacy and Safety of Sacubitril/Valsartan

    Cardiology (Switzerland), Vol. 142, Núm. 2, pp. 73-78